StockData
Cognition Therapeutics Inc logo

Cognition Therapeutics Inc (CGTX) stock

CGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.60−0.03 (-4.75%)

Close on Nov 18, 2026Market cap $57.06MP/E –Yield –

Cognition Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cognition Therapeutics's price to book ratio was 1.9× on Nov 11, 2026, against 4.2× a year earlier. Over the last 5 years it ranged from 0.8× to 22.5×, with a median of 1.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.9×−1.3
2025Dec 31, 20253.3×+1.3
2024Dec 31, 20242.0×+0.0
2023Dec 29, 20231.9×+0.7
2022Dec 30, 20221.3×–

More Cognition Therapeutics figures

See a number that looks wrong?